Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Acute Leukemias

Phosphorylation of PML is essential for activation of C/EBPɛ and PU.1 to accelerate granulocytic differentiation

Abstract

Promyelocytic leukemia (PML) is a nuclear protein that functions as a regulator of transcription, cell proliferation, apoptosis and myeloid cell differentiation. PML is subjected to post-translational modifications such as sumoylation and phosphorylation. However, the physiological significance of these modifications, especially for myeloid cell differentiation, remains unclear. In this report, we found that four serine residues in the PML C-terminal region are highly phosphorylated in a myeloid cell line. Wild-type PML accelerated G-CSF-induced granulocytic differentiation, but a phosphorylation-deficient PML mutant failed. PML interacted with C/EBPɛ, a transcription factor essential for granulopoiesis, activated C/EBPɛ-mediated transcription in concert with p300 and accelerated C/EBPɛ-induced granulocytic differentiation. Phosphorylation of PML was required for stimulating C/EBPɛ-dependent transcription and accelerating C/EBPɛ-induced granulocytic differentiation. We also found that PML phosphorylation was required for stimulation of PU.1-dependent transcription and acceleration of PU.1-induced granulocytic differentiation. These results suggest that phosphorylation plays essential roles in the regulation of PML to accelerate granulocytic differentiation through multiple pathways.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5

Similar content being viewed by others

References

  1. Zhong S, Salomoni P, Pandolfi PP . The transcriptional role of PML and the nuclear body. Nat Cell Biol 2000; 2: E85–E90.

    Article  CAS  Google Scholar 

  2. de The H, Chomienne C, Lanotte M, Degos L, Dejean A . The t(15;17) translocation of acute promyelocytic leukaemia fuses the retinoic acid receptor alpha gene to a novel transcribed locus. Nature 1990; 347: 558–561.

    Article  CAS  Google Scholar 

  3. Wang ZG, Delva L, Gaboli M, Rivi R, Giorgio M, Cordon-Cardo C et al. Role of PML in cell growth and the retinoic acid pathway. Science 1998; 279: 1547–1551.

    Article  CAS  Google Scholar 

  4. Kastner P, Lawrence HJ, Waltzinger C, Ghyselinck NB, Chambon P, Chan S . Positive and negative regulation of granulopoiesis by endogenous RARalpha. Blood 2001; 97: 1314–1320.

    Article  CAS  Google Scholar 

  5. Muller S, Matunis MJ, Dejean A . Conjugation with the ubiquitin-related modifier SUMO-1 regulates the partitioning of PML within the nucleus. EMBO J 1998; 17: 61–70.

    Article  CAS  Google Scholar 

  6. Bernardi R, Scaglioni PP, Bergmann S, Horn HF, Vousden KH, Pandolfi PP . PML regulates p53 stability by sequestering Mdm2 to the nucleolus. Nat Cell Biol 2004; 6: 665–672.

    Article  CAS  Google Scholar 

  7. Yang S, Kuo C, Bisi JE, Kim MK . PML-dependent apoptosis after DNA damage is regulated by the checkpoint kinase hCds1/Chk2. Nat Cell Biol 2002; 4: 865–870.

    Article  CAS  Google Scholar 

  8. Hayakawa F, Privalsky ML . Phosphorylation of PML by mitogen-activated protein kinases plays a key role in arsenic trioxide-mediated apoptosis. Cancer Cell 2004; 5: 389–401.

    Article  CAS  Google Scholar 

  9. Scaglioni PP, Yung TM, Cai LF, Erdjument-Bromage H, Kaufman AJ, Singh B et al. A CK2-dependent mechanism for degradation of the PML tumor suppressor. Cell 2006; 126: 269–283.

    Article  CAS  Google Scholar 

  10. Nguyen LA, Pandolfi PP, Aikawa Y, Tagata Y, Ohki M, Kitabayashi I . Physical and functional link of the leukemia-associated factors AML1 and PML. Blood 2005; 105: 292–300.

    Article  CAS  Google Scholar 

  11. Lekstrom-Himes JA . The role of C/EBPɛin the terminal stages of granulocyte differentiation. Stem Cells 2001; 19: 125–133.

    Article  CAS  Google Scholar 

  12. Fisher RC, Scott EW . Role of PU.1 in hematopoiesis. Stem Cells 1998; 16: 25–37.

    Article  CAS  Google Scholar 

  13. Yoshida H, Ichikawa H, Tagata Y, Katsumoto T, Ohnishi K, Akao Y et al. PML-RARA inhibits PML IV enhancement of PU.1-induced C/EBPɛ expression in myeloid differentiation. Mol Cell Biol 2007; 16: 5819–5834.

    Article  Google Scholar 

  14. Kinashi T, Lee K, Ogawa M, Tohyama K, Tashiro K, Fukunaga R et al. Premature expression of the macrophage colony-stimulating factor receptor on a multipotential stem cell line does not alter differentiation lineages controlled by stromal cells used for coculture. J Exp Med 1991; 173: 1267–1279.

    Article  CAS  Google Scholar 

  15. Shimizu K, Kitabayashi I, Kamada N, Abe T, Maseki N, Suzukawa K et al. AML1-MTG8 leukemic protein induces the expression of granulocyte colony-stimulating factor (G-CSF) receptor through the up-regulation of CCAAT/enhancer binding protein epsilon. Blood 2000; 96: 288–296.

    CAS  Google Scholar 

  16. Kakizuka A, Miller Jr WH, Umesono K, Warrell Jr RP, Frankel SR, Murty VV et al. Chromosomal translocation t(15;17) in human acute promyelocytic leukemia fuses RAR alpha with a novel putative transcription factor, PML. Cell 1991; 66: 663–674.

    Article  CAS  Google Scholar 

  17. Nakajima H, Ihle JN . Granulocyte colony-stimulating factor regulates myeloid differentiation through CCAAT/enhancer-binding protein epsilon. Blood 2001; 98: 897–905.

    Article  CAS  Google Scholar 

  18. Verbeek W, Lekstrom-Himes J, Park DJ, Dang PM, Vuong PT, Kawano S et al. Myeloid transcription factor C/EBPɛ is involved in the positive regulation of lactoferrin gene expression in neutrophils. Blood 1999; 94: 3141–3150.

    CAS  Google Scholar 

  19. Engelhardt OG, Boutell C, Orr A, Ullrich E, Haller O, Everett RD . The homeodomain-interacting kinase PKM (HIPK-2) modifies ND10 through both its kinase domain and a SUMO-1 interaction motif and alters the posttranslational modification of PML. Exp Cell Res 2003; 283: 36–50.

    Article  CAS  Google Scholar 

  20. Aikawa Y, Nguyen LA, Isono K, Takakura N, Tagata Y, Schmitz ML et al. Roles of HIPK1 and HIPK2 in AML1- and p300-dependent transcription, hematopoiesis and blood vessel formation. EMBO J 2006; 25: 3955–3965.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

We thank Ms Yukiko Aikawa and Noriko Aikawa (National Cancer Center Research Institute) for technical assistance. This research was supported in part by a grant-in-aid from the Ministry of Education, Culture, Sports, Science and Technology of Japan, and by a grant from the Leukemia Study Group of the Ministry of Health, Labour and Welfare of Japan.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to I Kitabayashi.

Additional information

Supplementary Information accompanies the paper on the Leukemia website (http://www.nature.com/leu)

Supplementary information

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tagata, Y., Yoshida, H., Nguyen, L. et al. Phosphorylation of PML is essential for activation of C/EBPɛ and PU.1 to accelerate granulocytic differentiation. Leukemia 22, 273–280 (2008). https://doi.org/10.1038/sj.leu.2405024

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.leu.2405024

Keywords

This article is cited by

Search

Quick links